| Archived Events |
|---|
2008 PDA/EBE Conference on Biopharmaceutical Development and Manufacturing
06-24-08 -
06-25-08
Speaker: Vijay Yabannavar, Ph.D., VP, Process Development and Manufacturing
|
|
|
Needham 7th Annual Biotechnology & Medical Technology Conference
06-12-08 10:00 AM ET
Speaker: Ken Mohler, PhD, Co-founder, Senior Vice President of Research & Development, and Michelle Burris, Senior Vice President and Chief Financial Officer
|
|
|
Trubion Presents Positive Pre-clinical TRU-016 Data at ASCO
06-02-08
|
|
|
Bank of America 2008 Health Care Conference
05-13-08 1:20 PM PT
Speaker: Michelle Burris, Senior Vice President and Chief Financial Officer
|
|
The Four Seasons Hotel, Las Vegas, NV
|
Trubion First Quarter 2008 Earnings Conference Call
05-08-08 2:00 PM PT
|
|
|
Morgan Stanley Global Healthcare Unplugged Conference
04-30-08 9:50 AM ET
Speaker: Peter Thompson, MD, FACP, President, CEO and Chairman
|
|
The Ritz-Carlton, Key Biscayne, FL
|
2008 Gene Therapy of Arthritis and Related Disorders Annual Meeting
04-29-08
Speaker: Ken Mohler, Ph.D, SVP R&D Trubion
|
|
|
Cell Culture Engineering XI Conference
04-13-08
Speaker: Vijay Yabannavar, VP, Manufacturing
|
|
|
Invest Northwest CEO & Investor Forum
03-18-08 11:20 AM PT
Speaker: Ken Mohler, PhD, Co-founder, Senior Vice President of Research & Development
|
|
Bell Harbor International Conference Center, Seattle, WA
|
Trubion Fourth Quarter 2007 Earnings Conference Call
03-13-08 2:00 PM PT
|
|
|
Sanford Bernstein Biotechnology Conference
03-10-08
Speaker: Dr. Peter Thompson, President, CEO and Chairman
|
|
|
TRU-016 ASH 2007 Presentation
12-08-07 -
12-11-07
|
|
984.1 KB PDF
Data summary:
TRU-016 induces potent ADCC against primary B-CLL cells; TRU-016 demonstrates significant in vivo therapeutic efficacy in an SCID mouse xenograft leukemia/lymphoma model; TRU-016 induces potent apoptosis in primary CLL cells
Data presented by OSU investigators at the 49th annual meeting of the American Society of Hematology (ASH). The meeting was held Dec. 8-11, 2007, at the Georgia World Congress Center in Atlanta.
Title:
[801] Role of CD37 SMIP, a Novel Engineered Small Modular Immunopharmaceutical, in the Treatment of CLL
|
2007 Lazard Capital Markets Healthcare Investor Conference
11-27-07 -
11-28-07
Speaker: Peter Thompson, MD, FACP, President, CEO and Chairman
|
|
|
Trubion Third Quarter 2007 Earnings Conference Call
11-12-07 2:00 PM PT
|
|
|
Trubion ACR Conference Call
11-08-07 2:00 PM PT
|
|
|
2007 ACR Poster Presentations
11-08-07 8:00 AM -
11-09-07 5:00 PM
|
|
TRBN ACR Phase IIb Poster
686.0 KB PDF
TRBN ACR Retreatment Poster
327.0 KB PDF
Poster 309: Safety and Pharmacodynamics of Repeat Administration of TRU- 015, a CD20-Directed SMIP™ Therapeutic, in Subjects with Rheumatoid Arthritis
Poster L7: TRU-015 Improves Rheumatoid Arthritis Disease Activity in a Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 2 Dose Ranging Trial
|
2007 UBS Global Life Sciences Investor Conference
09-24-07 8:30 AM ET
Speaker: Peter Thompson, MD, FACP, President, CEO and Chairman
|
|
|
Bank of America 37th Annual Investment Conference
09-17-07 2:00 PM PT
Speaker: Peter Thompson, M.D., FACP, President, CEO and Chairman
|
|
893.3 KB PDF
San Francisco
|
Trubion Conference Call
09-10-07 1:30 PM PT
|
|
|
BioCentury NewsMakers Investor Conference
09-06-07 2:30 PM ET
Speaker: Peter Thompson, M.D., FACP, President, CEO and Chairman
|
|
|
Trubion Second Quarter 2007 Earnings Conference Call
08-13-07 2:00 PM PT
|
|
|
Needham & Company Biotechnology & Medical Technology Investor Conference
06-14-07
Speaker: Michelle Burris, CFO
|
|
|
2007 ASCO Annual Meeting - Poster Presentation
06-03-07 8:00 AM
|
|
384.4 KB PDF
Poster Title: Depletion of Normal and Malignant B Cells with a CD37-
specific SMIP Molecule
Poster Number: G1
Abstract No: 3063
Presenter: Charles Cerveny, MS
Time: Sunday, June 3, 2007 8:00 AM - 12:00 PM
|
Bank of America Healthcare Conference
05-30-07
Speaker: Peter Thompson, M.D., FACP, President, CEO and Chairman
|
|
|
Morgan Stanley Global HC Unplugged Conference
05-02-07
Speaker: Peter Thompson, M.D., FACP, President, CEO and Chairman
|
|
A copy of Trubion's current presentation can be found at:
http://investors.trubion.com/
|
Investor Presentation
April 2007
|
|
|
Publication: "Targeting CD37 Lymphoid Maligancies With a Novel Engineered SMIP"
04-17-07
|
|
386.8 KB PDF
Pre-published in Blood Journal online
|
Trubion Fourth Quarter and Year-End 2006 Earnings Conference Call
03-26-07 2:00 PM PT
|
|
|
Lehman Brothers 10th Annual Global Healthcare Conference
03-21-07 8:00 AM
Speaker: Peter Thompson, M.D., FACP, President, CEO and Chairman
|
|
A copy of the presentation slides can be found on the "Investors" section home page.
|
2007 Invest Northwest Investor and CEO Forum
03-20-07 8:40 AM PT
Speaker: Kendall Mohler, Ph.D., Senior Vice President, Research & Development
|
|
A copy of the presentation slides can be found on the "Investors" section home page.
|
2006 American Society of Hematology (ASH) Annual Meeting
12-09-06 -
12-12-06
|
|
Orange County Convention Center in Orlando, Florida
For more information, click here:
http://investors.trubion.com/releasedetail.cfm?ReleaseID=220834
|
Lazard Life Sciences Conference
11-28-06 11:30 AM ET
Speaker: Dr. Peter Thompson, President and Chief Executive Officer
|
|
The New York Palace Hotel
|
2006 American College of Rheumatology (ACR) Annual Meeting
11-12-06 8:00 AM -
4:30 PM ET
Speaker: Daniel Burge, M.D., Senior Vice President, Chief Medical Officer, Trubion Pharmaceuticals
|
|
224.9 KB PDF
Washington Convention Center in Washington, D.C.
|
Trubion TRU-015 Phase I Poster Presentation: EULAR Annual Meeting
06-21-06 -
06-24-06
Speaker: Dr. Dan Burge
|
|
|
